Develops and manufactures additives and functional products for various industries. Produces advanced materials, including copolyesters and films. Now — the numbers.
Revenue is spread across several lines; no single product carries the company.
This is an established company with proven profits.
The gap is $4.5B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 16.4× for every dollar of annual profit — around what a business like this usually costs.
Against companies in its own sector, it looks cheaper than 78% of them.
Analysts' average target sits 19% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
The price is looking for direction — no strong breakout, no collapse.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
Growth: Sales growth trails the sector average.
The stock trades 47% below its peak. The market has trimmed its expectations for the company.
Over the last 12 months, company executives reported 68 buys and 20 sells. Management buying with its own money is usually read as a good sign.
It pays out $3.35 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales fell about 4% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 35/100.
The growth engine is running at low revs right now. Report-card grade: 43/100.
On our five-subject report card, EMN sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: EMN is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.